An intranasal flu vaccine approved two decades ago may have underappreciated immune benefits

For decades, influenza vaccines have been judged largely by the antibodies they generate in the bloodstream, a measure that has remained the gold standard since the first flu immunizations were administered in the 1940s.



Original Source Link